Loading Video…
This browser does not support the Video element.
Participants in Moderna COVID-19 vaccine trial developed antibodies
The vaccine candidate will begin a 30,000-person study on July 27.
This browser does not support the Video element.
The vaccine candidate will begin a 30,000-person study on July 27.